Cargando…
Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
Extranodal natural killer/T-cell lymphoma (ENKTCL) is a rare form of non-Hodgkin lymphoma. This neoplasm is more prevalent in regions of Asia and Latin America and most commonly involves the sinonasal tract, presenting with signs of nasal obstruction, epistaxis, or sinus infection. It is a locally d...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476476/ https://www.ncbi.nlm.nih.gov/pubmed/28652944 http://dx.doi.org/10.7759/cureus.1260 |
_version_ | 1783244605649584128 |
---|---|
author | Althoff, Ashley Bibliowicz, Michael |
author_facet | Althoff, Ashley Bibliowicz, Michael |
author_sort | Althoff, Ashley |
collection | PubMed |
description | Extranodal natural killer/T-cell lymphoma (ENKTCL) is a rare form of non-Hodgkin lymphoma. This neoplasm is more prevalent in regions of Asia and Latin America and most commonly involves the sinonasal tract, presenting with signs of nasal obstruction, epistaxis, or sinus infection. It is a locally destructive and angioinvasive neoplasm. The treatment of ENKTCL is dependent on the extent of the tumor. For localized disease, the treatment is chemoradiation. For disseminated disease, treatment is mainly chemotherapy-based. This report describes a case of a 41-year-old Hispanic woman who initially presented with signs of nasal congestion for four weeks and was subsequently diagnosed and treated for chronic sinusitis. The patient underwent endoscopic surgery for persistent chronic sinusitis, with a presumptive diagnosis of allergic fungal rhinosinusitis based on clinical and radiographic presentation. The pathologic exam revealed a diagnosis of ENKTCL. The patient underwent three cycles of chemotherapy comprised of steroid (hydrocortisone), methotrexate, ifosfamide, pre-asparaginase, and etoposide (SMILE) followed by radiation, resulting in clinical and radiographic remission. On review of the literature, ENKTCL is very rare in the United States and diagnosis is commonly delayed due to non-specific signs. We report this case to increase awareness of this disease entity and remind clinicians to include this in the differential diagnosis of nasal obstruction. |
format | Online Article Text |
id | pubmed-5476476 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-54764762017-06-26 Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding Althoff, Ashley Bibliowicz, Michael Cureus Oncology Extranodal natural killer/T-cell lymphoma (ENKTCL) is a rare form of non-Hodgkin lymphoma. This neoplasm is more prevalent in regions of Asia and Latin America and most commonly involves the sinonasal tract, presenting with signs of nasal obstruction, epistaxis, or sinus infection. It is a locally destructive and angioinvasive neoplasm. The treatment of ENKTCL is dependent on the extent of the tumor. For localized disease, the treatment is chemoradiation. For disseminated disease, treatment is mainly chemotherapy-based. This report describes a case of a 41-year-old Hispanic woman who initially presented with signs of nasal congestion for four weeks and was subsequently diagnosed and treated for chronic sinusitis. The patient underwent endoscopic surgery for persistent chronic sinusitis, with a presumptive diagnosis of allergic fungal rhinosinusitis based on clinical and radiographic presentation. The pathologic exam revealed a diagnosis of ENKTCL. The patient underwent three cycles of chemotherapy comprised of steroid (hydrocortisone), methotrexate, ifosfamide, pre-asparaginase, and etoposide (SMILE) followed by radiation, resulting in clinical and radiographic remission. On review of the literature, ENKTCL is very rare in the United States and diagnosis is commonly delayed due to non-specific signs. We report this case to increase awareness of this disease entity and remind clinicians to include this in the differential diagnosis of nasal obstruction. Cureus 2017-05-19 /pmc/articles/PMC5476476/ /pubmed/28652944 http://dx.doi.org/10.7759/cureus.1260 Text en Copyright © 2017, Althoff et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Oncology Althoff, Ashley Bibliowicz, Michael Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding |
title | Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding |
title_full | Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding |
title_fullStr | Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding |
title_full_unstemmed | Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding |
title_short | Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding |
title_sort | extranodal natural killer/t-cell lymphoma: an incidental finding |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476476/ https://www.ncbi.nlm.nih.gov/pubmed/28652944 http://dx.doi.org/10.7759/cureus.1260 |
work_keys_str_mv | AT althoffashley extranodalnaturalkillertcelllymphomaanincidentalfinding AT bibliowiczmichael extranodalnaturalkillertcelllymphomaanincidentalfinding |